Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-082485

Chief Scientific Officer sold 8,000 shares at $16.33 ($130,640)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Michaelson Jennifer Chief Scientific Officer 2024-07-05 Sale 10b5-1 −8,000 $16.33 $130,640 123,942 D
Open-market sales · 8,000 sh · avg $16.33 · $130,640
Loading xslF345X05/ownership.xml…